BackOur services

Our reputation as a leading global corporate finance house, is built on our knowledge, sector focus and bespoke service offering.

View all
BackOur sectors

Helping clients achieve their goals through our sector insight and extensive market knowledge lies at the heart of our ethos.

View all

Healthcare

Maximising opportunities

We work closely with entrepreneurs and investors at the forefront of the global healthcare revolution. Our in-depth sector knowledge, combined with our technical capability, enables us to help corporates and investors capitalise on the enormous opportunities across the sector as they seek to consolidate and grow their market positions.

The ageing population, technological change, and increased demand for healthcare products and services, all create great opportunities in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. Our job is to help our clients maximise those opportunities.

< >

Our latest transactions

See our transactions

Clearwater has been very professional in leading the process involving candidates from all over the world.

Luc Bertholat, Partner, Naxicap Partners

Our Healthcare Team

The team were quickly able to identify the right partner for us and used their excellent relationship with the buyer to help negotiate a transaction that met our objectives.
Dan Smart, CEO, Proclinical

With in-depth knowledge and technical capability, our healthcare team has a great track record of delivering tailored solutions.

See our team

Over 65

deals advised upon

in the last 5 years

€9.4bn

in deal value

over the last 5 years

Over 40%

deals involving PE

in the last 5 years

Insights

  • Spotlight on: France

    With a strong rebound in dealdoing after the Q2 2020 lockdown, the French PE market remains the busiest in Europe – and deal-hungry sponsors with deep pockets should ensure processes remain heated in the coming months.

    Read more

  • Clearwater International Multiples Heatmap - Q4 2020

    A strong performance in the second half of the year meant that any drop-off in activity was not as pronounced as was first feared, with 2020 deal value and volume falling by just 5% and 6% year-on-year, respectively. At 11x, average multiples paid in PE-backed transactions across Europe reached a new high in the final quarter of the year.

    Read more

  • European overview

    While initially hit hard by the impact of the COVID-19 pandemic, the European deal market made a swift recovery in the second half of 2020.

    Read more
See more Insights
Scroll to Top